At a press conference in London today, Ontario’s Minister of Research and Innovation, John Milloy, is scheduled to announce the Province’s new $161 million Life Sciences Commercialization Strategy.
The bulk of the money ($114 million) is allocated to the Global Leadership Round in Genomics & Life Sciences (GL2), though $100 million of that was announced last year. Recent announcements under this program include $8.1 million for the International Barcode of Life Project, an $8.8 million grant to SickKids for autism genomics research, and $24.8 million to a posse of University of Toronto genomics researchers.
To read the full, original article click on this link: Ontario’s New Life Sciences Commercialization Strategy Announced by Minister of Research and Innovation John Milloy « The Cross-Border Biotech Blog
Author: Cross-Border Biotech Blog